Type I Interferon Signaling Augments Autoimmunity in Neuromyelitis Optica Spectrum Disorder

Documenti analoghi

• Genetic Insights Into Neuromyelitis Optica Spectrum Disorder
  di: Hisashi Murata, et al.
  Pubblicazione: (2025)
• Neuromyelitis Optica Spectrum Disorder: Clinical Features and Treatments Revisited
  di: Mitsuru Watanabe
  Pubblicazione: (2025)
• Efficacy of Ravulizumab During the Acute Phase of Neuromyelitis Optica Spectrum Disorder
  di: Koji Tsuzaki, et al.
  Pubblicazione: (2026)
• Pathogenic Roles of Age‐Associated B Cells in Neuromyelitis Optica Spectrum Disorder
  di: Eiichiro Amano, et al.
  Pubblicazione: (2025)
• Atypical Multiple Sclerosis Overlapping Features of Neuromyelitis Optica Spectrum Disorders ( NMOSD )
  di: Sepideh Paybast, et al.
  Pubblicazione: (2025)